Purpose of umbilical cord mesenchymal stem cell exosome
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD
- Publication Date
- 2017-02-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of stem cell culture, in particular to the use of umbilical cord mesenchymal stem cell exosomes. Background technique
[0002] Peripheral hematopoietic stem cells are hematopoietic stem cells present in peripheral blood. In 1979, Goldman et al. collected cryopreserved peripheral blood cells for a group of chronic myeloid leukemia patients in the accelerated phase or blast transition phase at the initial diagnosis, so that the patients returned to the chronic phase, and began the clinical application of peripheral blood hematopoietic stem cell transplantation (PBSCT).
[0003] Under normal circumstances, the content of stem / progenitor cells in peripheral blood accounts for 0.01% to 0.1% of mononuclear cells, which is equivalent to 1% to 10% of bone marrow. After mobilization, CD34 in peripheral blood MNCs + The number of cells and CFU were significantly higher than those of bone marrow. So far, it has been found that...